PYC Therapeutics | PYC - Ebitda

Aktienkurs
1.45
Täglich Wechseln
0.01 0.56%
Monatlich
19.67%
Jährlich
17.72%
Q2 Prognose
1.21




Ebitda Veränderung Datum
Avita Medical AUD -9.69M 12.21M 2025-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12